Traws Pharma files prospectus supplement for up to $5.575M ATM offering

Traws Pharma, Inc.

Company may sell up to $5,575,709 in common stock under ATM agreement with Citizens JMP Securities.
Offering uses 'baby shelf' limitation under Form S-3; shelf registration declared effective July 9, 2026.
Original ATM agreement from March 2025 allowed up to $50M; this supplement caps current sales at baby shelf amount.
Prospectus supplement dated July 10, 2026 filed pursuant to Rule 424(b).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.